Seqirus has strengthened the 海角视频's vaccine response to influenza as its high-speed syringe filling and packing facility in Liverpool starts rolling out millions of doses.
The facility is the largest vaccine manufacturing site of its kind in the 海角视频, producing over 50 million doses of seasonal influenza vaccine each year, with the ability to increase production to 200 million doses in the event of an influenza pandemic.
The site now has a high-speed fill-and-finish facility, which enables start-to-finish onshore manufacturing, where previously the vaccine would be sent abroad to be put into syringes and packed.
This enables Seqirus to complete the entire start-to-end vaccine manufacturing process at the Liverpool site and shortens the supply lead time by more than one to two weeks per batch.
The new facility represents an investment of nearly £50m, creating more than 120 jobs.
It was completed over a four-year period and is the result of a collaboration with local government who contributed £1m.
Don't miss a thing - sign up for your free North West newsletter - and follow us on LinkedIn
Email newsletters
BusinessLive is your home for business news from around the North West- and you can stay in touch with all the latest news from Greater Manchester, Liverpool City Region, Cheshire, Lancashire and Cumbria through our email alerts.
You can sign up to receive daily morning news bulletins from every region we cover and to weekly email bulletins covering key economic sectors from manufacturing to technology and enterprise. And we'll send out breaking news alerts for any stories we think you can't miss.
Visit our email preference centre to sign up to all the latest news from BusinessLive.
For all the latest stories, views, polls and more - and the news as it breaks - .
The new filling line will allow Seqirus to produce finished doses of influenza vaccine more quickly in the event of an influenza pandemic.
Most Read
Nigel Hilton, head of manufacturing and site head at Liverpool, said: "Bringing the fill-and-finish capability in house means we can simplify the supply chain, allowing us to shorten lead times to supply vaccines to the 海角视频 and other governments who need them.
"The £50m investment also benefits the local Liverpool economy with the introduction of more than 120 high value local jobs at the site, with even more jobs opening up as we expand our supply capability further."
Sharon McHale, head of global policy and government affairs at Seqirus, added: "This is a proud moment for Seqirus and our local partners who helped make this possible.
"Our ability to make vaccines from start-to-finish on our Liverpool site enables us to be better assured of a continued supply of seasonal influenza vaccines in the 海角视频 and beyond, and speed response to the next influenza pandemic."